Celularity (CELU) Announces CFO Transition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/9/2026
- Hut 8 Mining Corp. (HUT) PT Raised to $55 at KBW As Management Delivers
- UK's Ofcom requires tech firms to create crisis response plans
- Exclusive-SpaceX plans to set IPO price at $135 per share, targeting record $75 billion raise, source says
- Salesforce to acquire metering platform M3TER for consumption billing
- Micron to deliver 'another strong quarter', Goldman says
Celularity Announces Chief Financial Officer Transition
June 10, 2025 4:15 PM EDTFLORHAM PARK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (Celularity or the Company), a regenerative and cellular medicine company, today announced that it terminated the employment of its Chief Financial Officer (CFO), David Beers, effective immediately. Mr. Beers termination was not related to the Companys financial or operating results or to any disagreements or concerns regarding the Companys financial or reporting practices. Mr. Beers was terminated without cause under the terms of his employment agreement dated April 1, 2022, as... More
